TYPE IIB PROCOLLAGEN N-PROPEPTIDE INHIBITS ANGIGENESIS IN CARTILAGE

被引：0
|
作者：
Wang, Z. [1 ]
Bryan, J. [1 ]
Sandell, L. [1 ]
机构：
[1] Washington Univ, St Louis, MO USA
来源：
OSTEOARTHRITIS AND CARTILAGE | 2012年 / 20卷
关键词：
D O I：
10.1016/j.joca.2012.02.021
中图分类号：
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学（修复外科学）];
学科分类号：
摘要：
引用
收藏
页码：S57 / S58
页数：2
相关论文
共 50 条
  • [1] Cartilage Inhibits Angiogenesis via Type IIB Procollagen N-Propeptide
    Wang, Zhepeng
    Bryan, Jennifer
    Sandell, Linda
    GLYCOBIOLOGY, 2012, 22 (11) : 1563 - 1563
  • [2] The N-propeptide of type I procollagen functions intracellularly
    Oganesian, A.
    Au, S.
    Pace, J.
    Bornstein, P.
    MATRIX BIOLOGY, 2006, 25 : S70 - S70
  • [3] PLEOMORPHISM IN TYPE-I COLLAGEN FIBRILS PRODUCED BY PERSISTENCE OF THE PROCOLLAGEN N-PROPEPTIDE
    HULMES, DJS
    KADLER, KE
    MOULD, AP
    HOJIMA, Y
    HOLMES, DF
    CUMMINGS, C
    CHAPMAN, JA
    PROCKOP, DJ
    JOURNAL OF MOLECULAR BIOLOGY, 1989, 210 (02) : 337 - 345
  • [4] Evaluation of a fully automated assay for serum procollagen type I n-propeptide in osteoporosis.
    Garnero, P
    Delmas, PD
    JOURNAL OF BONE AND MINERAL RESEARCH, 2002, 17 : S316 - S316
  • [5] Procollagen type I N-propeptide is a predictor of skeletal morbidity in patients with malignant osteolytic bone disease on bisphosphonates
    Joerger, M.
    Templeton, A.
    Koeberle, D.
    Engler, H.
    Riesen, W. F.
    Thuerlimann, B.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 67 (05) : 1137 - 1144
  • [6] Procollagen type I N-propeptide is a predictor of skeletal morbidity in patients with malignant osteolytic bone disease on bisphosphonates
    M. Joerger
    A. Templeton
    D. Köberle
    H. Engler
    W. F. Riesen
    B. Thürlimann
    Cancer Chemotherapy and Pharmacology, 2011, 67 : 1137 - 1144
  • [7] The globular domain of the proα1(I) N-propeptide is not required for secretion, processing by procollagen N-proteinase, or fibrillogenesis of type I collagen in mice
    Bornstein, P
    Walsh, V
    Tullis, J
    Stainbrook, E
    Bateman, JF
    Hormuzdi, SG
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (04) : 2605 - 2613
  • [8] Analytical performance and clinical utility of a fully automated assay for serum procollagen type 1 N-propeptide (P1NP)
    Gamero, P.
    Vergnaud, P.
    Samoszuk, M.
    Hoyle, N.
    CLINICAL CHEMISTRY, 2007, 53 (06) : A188 - A188
  • [9] Clinical significance of serum transforming growth factor-β1 and procollagen type I N-propeptide in post-tuberculosis tracheobronchial stenosis
    Wu, Yongchang
    Li, Yishi
    Bai, Yang
    Jiang, Jinyue
    Wang, Xiaohui
    Chen, Yi
    Wang, Xin
    Huang, Guichuan
    Gan, Yiling
    Li, You
    Guo, Shuliang
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2021, 21 (06)
  • [10] Cysteine-rich Domain Of Type III Collagen N-propeptide Inhibits Fibroblast Activation By Attenuating Tgfβ Signaling
    Brisson, Becky K.
    Stewart, Daniel C.
    Burgwin, Chelsea
    Volk, Susan W.
    WOUND REPAIR AND REGENERATION, 2021, 29 (03) : A24 - A24
12345